关于定义急性呼吸窘迫综合征的效用及过去与当前定义效用的共识声明——一项德尔菲研究的方案
该文为一项德尔菲研究的方案,旨在收集全球专家对急性呼吸窘迫综合征(ARDS)概念框架的意见,评估当前及过去定义中各组成部分的效用,并探讨亚表型的作用。计划选取35–40名不同背景的专家,采用选择题或7点李克特量表陈述进行迭代德尔菲轮次,直至所有陈述达成稳定的同意或不同意。共识定义为选择题或李克特量表陈述获得≥80%的同意或不同意票;从第二轮起用非参数χ2检验或Kruskal Wallis检验检查稳定性,p值≥0.05定义为稳定。研究已获伦理批准豁免,方案注册号为NCT06159465。
要点
- 计划选取35–40名不同背景专家参与德尔菲研究,就ARDS定义效用及亚表型作用达成共识。
- 共识阈值:选择题或7点李克特量表陈述获得≥80%的同意或不同意票。
- 稳定性检查从第二轮德尔菲起采用非参数χ2检验或Kruskal Wallis检验,p值≥0.05定义为稳定。
- 德尔菲轮次将持续至所有陈述达成稳定的同意或不同意。
- 研究已获NMC Healthcare Regional Research Ethics Committee, Dubai伦理批准豁免(NMCHC/CR/DXB/REC/APP/002),注册号NCT06159465。
适用人群与场景
- 计划选取35–40名不同背景的专家组成专家组,基于预先定义的标准筛选。
诊断标准与关键阈值
- 共识标准:选择题或7点李克特量表陈述获得≥80%的同意或不同意票。
- 稳定性标准:从第二轮德尔菲起,非参数χ2检验或Kruskal Wallis检验p值≥0.05定义为稳定。
研究设计与关键结果
- 研究设计:德尔菲研究方案,计划进行迭代德尔菲轮次,采用选择题或7点李克特量表陈述。
- 共识定义:选择题或李克特量表陈述获得≥80%的同意或不同意票。
- 稳定性检查:从第二轮起采用非参数χ2检验或Kruskal Wallis检验,p值≥0.05定义为稳定。
证据类型、等级与局限
- 证据类型:德尔菲研究方案。
- 局限:原文未报告局限性。
对床旁实践的改变
- 原文未据此给出推荐。
指南或共识出处
- 研究方案注册号:NCT06159465。
- 报告规范:CREDES指导。
- 伦理批准:NMC Healthcare Regional Research Ethics Committee, Dubai(NMCHC/CR/DXB/REC/APP/002)。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「红旗征与不能漏的情况」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
INTRODUCTION: Acute respiratory distress syndrome (ARDS), marked by acute hypoxemia and bilateral pulmonary infiltrates, has been defined in multiple ways since its first description. This Delphi study aims to collect global opinions on the conceptual framework of ARDS, assess the usefulness of components within current and past definitions and investigate the role of subphenotyping. The varied expertise of the panel will provide valuable insights for refining future ARDS definitions and improving clinical management.
METHODS: A diverse panel of 35-40 experts will be selected based on predefined criteria. Multiple choice questions (MCQs) or 7-point Likert-scale statements will be used in the iterative Delphi rounds to achieve consensus on key aspects related to the utility of definitions and subphenotyping. The Delphi rounds will be continued until a stable agreement or disagreement is achieved for all statements.
ANALYSIS: Consensus will be considered as reached when a choice in MCQs or Likert-scale statement achieved ≥80% of votes for agreement or disagreement. The stability will be checked by non-parametric χ2 tests or Kruskal Wallis test starting from the second round of Delphi process. A p-value ≥0.05 will be used to define stability.
ETHICS AND DISSEMINATION: The study will be conducted in full concordance with the principles of the Declaration of Helsinki and will be reported according to CREDES guidance. This study has been granted an ethical approval waiver by the NMC Healthcare Regional Research Ethics Committee, Dubai (NMCHC/CR/DXB/REC/APP/002), owing to the nature of the research. Informed consent will be obtained from all panellists before the start of the Delphi process. The study will be published in a peer-review journal with the authorship agreed as per ICMJE requirements.
TRIAL REGISTRATION NUMBER: NCT06159465.
参考来源
- Nasa P, Bos LD, Estenssoro E, et al. Consensus statements on the utility of defining ARDS and the utility of past and current definitions of ARDS-protocol for a Delphi study. BMJ Open. 2024. PMID: 38670604. doi:10.1136/bmjopen-2023-082986
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。